Concepedia

Michael Yeh

MY

9

Publications

869

Citations

9

H-Index

1992

Active since

Affiliations

Apellis Pharmaceuticals (United States)(Current)

Swedish Orphan Biovitrum (Sweden)

RWTH Aachen University

Hôpital Saint-Louis

St James's University Hospital

Michael Yeh is an author at Apellis Pharmaceuticals (United States) specializing in medicine, clinical chemistry, and medical laboratory science.

ORCID

Top concepts

Publications per year

1992–2024

9

Publications

9

Circulating Levels of Cytokines and Their Endogenous Modulators in Patients With Mild to Severe Congestive Heart Failure Due to Coronary Artery Disease or Hypertension

MARCO TESTA, Michael Yeh, Paul C. Lee et al. · Journal of the American College of Cardiology · 1996 · 555 citations

, , +9

Sox6 is required for normal fiber type differentiation of fetal skeletal muscle in mice

Nobuko Hagiwara, Michael Yeh, Ann G. Liu · Developmental Dynamics · 2007 · 150 citations · Full text

Nonselective β-Adrenergic Blockade With Carvedilol Does Not Hinder the Benefits of Exercise Training in Patients With Congestive Heart Failure

Laura A. Demopoulos, Michael Yeh, Marco Gentilucci et al. · Circulation · 1997 · 58 citations

Management of acute breakthrough hemolysis with intensive pegcetacoplan dosing in patients with PNH

Morag Griffin, Richard J. Kelly, Jens Panse et al. · Blood Advances · 2024 · 30 citations · Full text

, , +17

Improved patient-reported health impact of multiple sclerosis: The ENABLE study of PR-fampridine

Richard Macdonell, Guy Nagels, David Laplaud et al. · Multiple Sclerosis Journal · 2015 · 25 citations

Rows per page

1–5 of 9